Key Insights The projected fair value for LivaNova is US$76.63 based on 2 Stage Free Cash Flow to Equity Current share...
LONDON, June 06, 2024--LivaNova announced preliminary results for the unipolar cohort of the RECOVER study, assessing use of VNS Therapy in treatment-resistant depression.
LivaNova PLC ( NASDAQ:LIVN ), might not be a large cap stock, but it led the NASDAQGS gainers with a relatively large...